Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Functional Attributes of Antibodies, Effector Cells, and Target Cells Affecting NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity.

Temming AR, de Taeye SW, de Graaf EL, de Neef LA, Dekkers G, Bruggeman CW, Koers J, Ligthart P, Nagelkerke SQ, Zimring JC, Kuijpers TW, Wuhrer M, Rispens T, Vidarsson G.

J Immunol. 2019 Dec 15;203(12):3126-3135. doi: 10.4049/jimmunol.1900985. Epub 2019 Nov 20.

PMID:
31748349
2.

Differential interaction between DARC and SDF-1 on erythrocytes and their precursors.

Klei TRL, Aglialoro F, Mul FPJ, Tol S, Ligthart PC, Seignette IM, Geissler J, van den Akker E, van Bruggen R.

Sci Rep. 2019 Nov 7;9(1):16245. doi: 10.1038/s41598-019-52186-6.

3.

Complement C3 inhibition by compstatin Cp40 prevents intra- and extravascular hemolysis of red blood cells.

Baas I, Delvasto-Nuñez L, Ligthart P, Brouwer C, Folman C, Reis ES, Ricklin D, Lambris JD, Wouters D, de Haas M, Jongerius I, Zeerleder SS.

Haematologica. 2020 Jan 31;105(2):e57-e60. doi: 10.3324/haematol.2019.216028. Print 2020. No abstract available.

4.

Development of a recombinant anti-Vel immunoglobulin M to identify Vel-negative donors.

van der Rijst MVE, Lissenberg-Thunnissen SN, Ligthart PC, Visser R, Jongerius JM, Voorn L, Veldhuisen B, Vidarsson G, van den Akker E, van der Schoot CE.

Transfusion. 2019 Apr;59(4):1359-1366. doi: 10.1111/trf.15147. Epub 2019 Jan 31.

PMID:
30702752
5.

Multiplex blood group typing by cellular surface plasmon resonance imaging.

Szittner Z, Bentlage AEH, van der Donk E, Ligthart PC, Lissenberg-Thunnissen S, van der Schoot CE, Vidarsson G.

Transfusion. 2019 Feb;59(2):754-761. doi: 10.1111/trf.15071. Epub 2018 Nov 29.

PMID:
30488958
6.

Acute hemolytic transfusion reaction due to a warm reactive anti-A1.

Helmich F, Baas I, Ligthart P, Bosch M, Jonkers F, de Haas M, van der Graaf F.

Transfusion. 2018 May;58(5):1163-1170. doi: 10.1111/trf.14537. Epub 2018 Feb 26.

PMID:
29484668
7.

Glycophorin-C sialylation regulates Lu/BCAM adhesive capacity during erythrocyte aging.

Klei TRL, de Back DZ, Asif PJ, Verkuijlen PJJH, Veldthuis M, Ligthart PC, Berghuis J, Clifford E, Beuger BM, van den Berg TK, van Zwieten R, El Nemer W, van Bruggen R.

Blood Adv. 2018 Jan 3;2(1):14-24. doi: 10.1182/bloodadvances.2017013094. eCollection 2018 Jan 9.

8.

RHD genotype and zygosity analysis in the Chinese Southern Han D+, D- and D variant donors using the multiplex ligation-dependent probe amplification assay.

Ji YL, Luo H, Wen JZ, Haer-Wigman L, Veldhuisen B, Wei L, Wang Z, Ligthart P, Lodén-van Straaten M, Fu YS, van der Schoot CE, Luo GP.

Vox Sang. 2017 Oct;112(7):660-670. doi: 10.1111/vox.12554. Epub 2017 Aug 18.

PMID:
28833187
9.

Patients with IgG1-anti-red blood cell autoantibodies show aberrant Fc-glycosylation.

Sonneveld ME, de Haas M, Koeleman C, de Haan N, Zeerleder SS, Ligthart PC, Wuhrer M, van der Schoot CE, Vidarsson G.

Sci Rep. 2017 Aug 15;7(1):8187. doi: 10.1038/s41598-017-08654-y.

10.

Antigen specificity determines anti-red blood cell IgG-Fc alloantibody glycosylation and thereby severity of haemolytic disease of the fetus and newborn.

Sonneveld ME, Koelewijn J, de Haas M, Admiraal J, Plomp R, Koeleman CA, Hipgrave Ederveen AL, Ligthart P, Wuhrer M, van der Schoot CE, Vidarsson G.

Br J Haematol. 2017 Feb;176(4):651-660. doi: 10.1111/bjh.14438. Epub 2016 Nov 28.

PMID:
27891581
11.

Fetal RHD genotyping after bone marrow transplantation.

Thurik FF, Page-Christiaens GC, Ait Soussan A, Ligthart PC, Cheroutre GM, Bossers B, Veldhuisen B, van der Schoot CE, de Haas M.

Transfusion. 2016 Aug;56(8):2122-6. doi: 10.1111/trf.13669. Epub 2016 May 30.

PMID:
27239725
12.

Frequency and characterization of known and novel RHD variant alleles in 37 782 Dutch D-negative pregnant women.

Stegmann TC, Veldhuisen B, Bijman R, Thurik FF, Bossers B, Cheroutre G, Jonkers R, Ligthart P, de Haas M, Haer-Wigman L, van der Schoot CE.

Br J Haematol. 2016 May;173(3):469-79. doi: 10.1111/bjh.13960. Epub 2016 Mar 27.

PMID:
27018217
13.

Knowledge management, health information technology and nurses' work engagement.

Hendriks PH, Ligthart PE, Schouteten RL.

Health Care Manage Rev. 2016 Jul-Sep;41(3):256-66. doi: 10.1097/HMR.0000000000000075.

PMID:
26052786
14.

Impact of genetic variation in the SMIM1 gene on Vel expression levels.

Haer-Wigman L, Stegmann TC, Solati S, Ait Soussan A, Beckers E, van der Harst P, van Hulst-Sundermeijer M, Ligthart P, van Rhenen D, Schepers H, de Haas M, van der Schoot CE.

Transfusion. 2015 Jun;55(6 Pt 2):1457-66. doi: 10.1111/trf.13014. Epub 2015 Feb 3.

PMID:
25647324
15.

Prophylactic anti-D preparations display variable decreases in Fc-fucosylation of anti-D.

Kapur R, Della Valle L, Verhagen OJ, Hipgrave Ederveen A, Ligthart P, de Haas M, Kumpel B, Wuhrer M, van der Schoot CE, Vidarsson G.

Transfusion. 2015 Mar;55(3):553-62. doi: 10.1111/trf.12880. Epub 2014 Sep 19.

PMID:
25234110
16.

Novel alleles at the Kell blood group locus that lead to Kell variant phenotype in the Dutch population.

Ji Y, Veldhuisen B, Ligthart P, Haer-Wigman L, Jongerius J, Boujnan M, Ait Soussan A, Luo G, Fu Y, van der Schoot CE, de Haas M.

Transfusion. 2015 Feb;55(2):413-21. doi: 10.1111/trf.12838. Epub 2014 Aug 25.

PMID:
25156717
17.

Low anti-RhD IgG-Fc-fucosylation in pregnancy: a new variable predicting severity in haemolytic disease of the fetus and newborn.

Kapur R, Della Valle L, Sonneveld M, Hipgrave Ederveen A, Visser R, Ligthart P, de Haas M, Wuhrer M, van der Schoot CE, Vidarsson G.

Br J Haematol. 2014 Sep;166(6):936-45. doi: 10.1111/bjh.12965. Epub 2014 Jun 7.

18.

Molecular analysis of immunized Jr(a-) or Lan- patients and validation of a high-throughput genotyping assay to screen blood donors for Jr(a-) and Lan- phenotypes.

Haer-Wigman L, Ait Soussan A, Ligthart P, de Haas M, van der Schoot CE.

Transfusion. 2014 Jul;54(7):1836-46. doi: 10.1111/trf.12544. Epub 2014 Jan 24.

PMID:
24456066
19.

Molecular analysis of the York antigen of the Knops blood group system.

Veldhuisen B, Ligthart PC, Vidarsson G, Roels I, Folman CC, van der Schoot CE, de Haas M.

Transfusion. 2011 Jul;51(7):1389-96. doi: 10.1111/j.1537-2995.2010.02999.x. Epub 2011 Jan 7.

PMID:
21214579
20.

KEL*02 alleles with alterations in and around exon 8 in individuals with apparent KEL:1,-2 phenotypes.

Wester ES, Steffensen R, Ligthart PC, Vad J, de Haas M, Storry JR, Olsson ML.

Vox Sang. 2010 Aug 1;99(2):150-7. doi: 10.1111/j.1423-0410.2010.01334.x. Epub 2010 Apr 4.

PMID:
20384970
21.

Anti-e found in a case of hemolytic disease of the fetus and newborn make use of the IGHV3 superspecies genes.

Dohmen SE, Muit J, Ligthart PC, Verhagen OJ, van der Schoot CE.

Transfusion. 2008 Jan;48(1):194-5. doi: 10.1111/j.1537-2995.2007.01559.x. No abstract available.

PMID:
18184235
22.

The restricted use of IGHV3 superspecies genes in anti-Rh is not limited to hyperimmunized anti-D donors.

Dohmen SE, Verhagen OJ, Muit J, Ligthart PC, van der Schoot CE.

Transfusion. 2006 Dec;46(12):2162-8.

PMID:
17176330
23.

RHD(T201R, F223V) cluster analysis in five different ethnic groups and serologic characterization of a new Ethiopian variant DARE, the DIII type 6, and the RHD(F223V).

Grootkerk-Tax MG, van Wintershoven JD, Ligthart PC, van Rhenen DJ, van der Schoot CE, Maaskant-van Wijk PA.

Transfusion. 2006 Apr;46(4):606-15.

PMID:
16584437
24.

Section 1C: Assessment of the functional activity and IgG Fc receptor utilisation of 64 IgG Rh monoclonal antibodies. Coordinator's report.

Kumpel BM, Beliard R, Brossard Y, Edelman L, de Haas M, Jackson DJ, Kooyman P, Ligthart PC, Monchâtre E, Overbeeke MA, Puillandre P, de Romeuf C, Wilkes AM.

Transfus Clin Biol. 2002 Jan;9(1):45-53.

PMID:
11889899
25.

Partial expression of RHc on the RHD polypeptide.

Faas BH, Beuling EA, Ligthart PC, van Rhenen DJ, van der Schoot CE.

Transfusion. 2001 Sep;41(9):1136-42.

PMID:
11552071
26.

DAR, a new RhD variant involving exons 4, 5, and 7, often in linkage with ceAR, a new Rhce variant frequently found in African blacks.

Hemker MB, Ligthart PC, Berger L, van Rhenen DJ, van der Schoot CE, Wijk PA.

Blood. 1999 Dec 15;94(12):4337-42.

PMID:
10590079
27.

Involvement of Gly96 in the formation of the Rh26 epitope.

Faas BH, Ligthart PC, Lomas-Francis C, Overbeeke MA, von dem Borne AE, van der Schoot CE.

Transfusion. 1997 Nov-Dec;37(11-12):1123-30.

PMID:
9426634
28.

Lower antigen site density and weak D immunogenicity cannot be explained by structural genomic abnormalities or regulatory defects of the RHD gene.

Beckers EA, Faas BH, Ligthart P, Overbeeke MA, von dem Borne AE, van der Schoot CE, van Rhenen DJ.

Transfusion. 1997 Jun;37(6):616-23.

PMID:
9191822
29.

Molecular background of VS and weak C expression in blacks.

Faas BH, Beckers EA, Wildoer P, Ligthart PC, Overbeeke MA, Zondervan HA, von dem Borne AE, van der Schoot CE.

Transfusion. 1997 Jan;37(1):38-44.

PMID:
9024488
30.

Characterization of the hybrid RHD gene leading to the partial D category IIIc phenotype.

Beckers EA, Faas BH, Ligthart P, Simsek S, Overbeeke MA, von dem Borne AE, van Rhenen DJ, van der Schoot CE.

Transfusion. 1996 Jun;36(6):567-74.

PMID:
8669091
31.

The RoHar antigenic complex is associated with a limited number of D epitopes and alloanti-D production: a study of three unrelated persons and their families.

Beckers EA, Porcelijn L, Ligthart P, Vermey H, Von dem Borne AE, Overbeeke MA, van Rhenen DJ.

Transfusion. 1996 Feb;36(2):104-8.

PMID:
8614957
32.

Rh DNA analysis.

Maaskant-Van Wijk PA, Faas BH, Wildoer P, Ligthart PC, Overbeeke MA, von dem Borne AE, van Rhenen DJ, van der Schoot CE.

Transfus Clin Biol. 1996;3(6):507-10. No abstract available.

PMID:
9018817
33.

Reactions of anti-D monoclonal antibodies with rhesus D variant cells.

Overbeeke MA, Van Rhenen DJ, Ligthart PC, Vermey J, de Ruiter JA, Kruit GV, Langendam M, Porcelijn L, von dem Borne AE.

Transfus Clin Biol. 1996;3(6):397-9. No abstract available.

PMID:
9018797
34.

Evaluation of combined coramine-electroshock therapy in the treatment of schizophrenia.

LIGTHART PW, JOHNSTON RP, SUSSMAN E.

Am J Psychiatry. 1956 Feb;112(8):619-23. No abstract available.

PMID:
13292549

Supplemental Content

Loading ...
Support Center